Cargando…
Targeted treatments after chemoradiotherapy failure in a patient with relapsed, advanced non‑small cell lung cancer with on‑therapy circulating tumor biomarker monitoring: A case report
Ongoing investigations of targeted therapeutic agents and their increased clinical applications, together with research in genomics and proteomics, have explored a variety of novel approaches for treatment of lung cancer, and ‘molecular subtypes’ have been defined based on specific actionable geneti...
Autores principales: | Bi, Yinghui, Xia, Chaoran, Zhang, Xinglin, Liu, Haixin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436159/ https://www.ncbi.nlm.nih.gov/pubmed/37600327 http://dx.doi.org/10.3892/ol.2023.13993 |
Ejemplares similares
-
Circulating microRNA biomarkers for lung cancer detection in Western populations
por: Yu, Haixin, et al.
Publicado: (2018) -
Predictive model of the first failure pattern in patients receiving definitive chemoradiotherapy for inoperable locally advanced non-small cell lung cancer (LA-NSCLC)
por: Zhu, Xueru, et al.
Publicado: (2020) -
Muscle Loss after Chemoradiotherapy as a Biomarker of Distant Failures in Locally Advanced Cervical Cancer
por: Lee, Jie, et al.
Publicado: (2020) -
Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer
por: Hu, Wenwei, et al.
Publicado: (2017) -
Circulating MicroRNA Biomarkers for Lung Cancer Detection in East Asian Populations
por: Yu, Haixin, et al.
Publicado: (2019)